Tyzeka (telbivudine) / Novartis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tyzeka (telbivudine) / Novartis
ChiCTR-OCC-12001987: The effects of telbivudine treatment on circulating Tregs and its significance in CHB patients

Completed
N/A
41
 
none ;telbivudine
Institute for Infectious Diseases, Southwest Hospital, Third Military Medical University; The State Nuture Science Foundation, China, From the national scientific research project
Hepatitis B
 
 
ChiCTR-TRC-09000615: Pre-operative application of Teltivudine to improve hepatic function in patients with Primary hepatic cancer and positive HBV-DNA of low-concentration

Completed
N/A
60
 
Telbivudine was given before operation ;no antivirus drug before operation
East hepatobiliary hospital; Level of the institution:, Self funding
Primary liver cancer (hepatic cell carcinoma, HCC)
 
 

Download Options